Mostafa Kamal, CEO, Magellan Rx Management at MAGELLAN HEALTH INC (MGLN), sold 604 shares at $83.00 ($50K) on 2017-09-13, disclosed to the SEC on 2017-09-14.
Open-market sale of $50k MGLN by CEO, Magellan Rx Management. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.00 | 19 | $2K | 3.1% |
| 2 | $83.00 | 585 | $49K | 96.9% |
| Total | $83.00 avg | 604 | $50K | 100% |
| Filing → |
| MGLN | SELL | 2020-11-12 | $979K | — | Filing → |
| MGLN | SELL | 2020-11-06 | $1.1M | — | Filing → |
| MGLN | SELL | 2020-10-20 | $15K | — | Filing → |